cisplatin,pemetrexed,pembrolizumab,gemcitabine
merck
['keynote,671', 'nsclc', 'ts,perio,1', 'pembro', 'sclc', 'ts,perio,i', 'lcsm,(-blcsm)', 'keynote-671']
 keynote-671 perioperative pembrolizumab appears promising for pts w/ resectable stage ii-iiib nsclc efs benefit hr 0.58 early os benefit hr 0.73 #asco23 #lcsm 
Thoracic Medical Oncologist, Assistant Professor @MDAndersonNews | Interested in patient education, PROs, personalized care | 🫁#cancer #lcsm | Views are my own